Charles University Motol University Hospital Prague Czech Republic

Zobrazit více v PubMed

Sigwart U. Non-surgical myocardial reduction for hypertrophic obstructive cardiomyopathy. Lancet. 1995;346:211–4. PubMed

Cribier A, Eltchaninoff H, Bash A, et al. Percutaneous transcatheter implantation of an aortic valve prosthesis for calcific aortic stenosis: first human case description. Circulation. 2002;106:3006–8. PubMed

Popma JJ, Deeb GM, Yakubov SJ, et al. Transcatheter aortic-valve replacement with a self-expanding valve in low-risk patients. N Engl J Med. 2019;380:1706–15. PubMed

Mack MJ, Leon MB, Thourani VH, et al. Transcatheter aortic-valve replacement with a balloon-expandable valve in low-risk patients. N Engl J Med. 2019;380:1695–705. PubMed

Makkar RR, Thourani VH, Mack MJ, et al. Five-year outcomes of transcatheter or surgical aortic-valve replacement. N Engl J Med. 2020;382:799–809. PubMed

Buzzatti N, Romano V, De Backer O, et al. Coronary access after repeated transcatheter aortic valve implantation. JACC Cardiovascular Imaging. 2019;13:508–15. PubMed

Dvir D, Leipsic J, Blanke P, et al. Coronary obstruction in transcatheter aortic valve-in-valve implantation preprocedural evaluation, device selection, protection, and treatment. Circ Cardiovasc Interv. 2015;8:e002079. PubMed

Willson AB, Rodès-Cabau J, Wood DA, et al. Transcatheter aortic valve replacement with the St. Jude Medical Portico valve first-in-human experience. JACC. 2012;60:581–6. PubMed

Vrachatis DA, Vavuranakis M, Tsoukala S, et al. TAVI: valve in valve. a new field for structuralists? Literature review. Hell J Cardiol. 2020;61:148–53. PubMed